108 related articles for article (PubMed ID: 7473146)
1. Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor?
Rangachari PK; Betti PA; Prior ET; Roberts LJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):611-7. PubMed ID: 7473146
[TBL] [Abstract][Full Text] [Related]
2. Prostanoid-induced relaxation of precontracted cat ciliary muscle is mediated by EP2 and DP receptors.
Chen J; Woodward DF
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3195-201. PubMed ID: 1328113
[TBL] [Abstract][Full Text] [Related]
3. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.
Giles H; Leff P; Bolofo ML; Kelly MG; Robertson AD
Br J Pharmacol; 1989 Feb; 96(2):291-300. PubMed ID: 2924081
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice.
Minami T; Okuda-Ashitaka E; Mori H; Ito S; Hayaishi O
J Pharmacol Exp Ther; 1996 Sep; 278(3):1146-52. PubMed ID: 8819497
[TBL] [Abstract][Full Text] [Related]
5. Further studies on ocular responses to DP receptor stimulation.
Woodward DF; Spada CS; Hawley SB; Williams LS; Protzman CE; Nieves AL
Eur J Pharmacol; 1993 Jan; 230(3):327-33. PubMed ID: 8440310
[TBL] [Abstract][Full Text] [Related]
6. The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C.
Hamid-Bloomfield S; Payne AN; Petrovic AA; Whittle BJ
Br J Pharmacol; 1990 Aug; 100(4):761-6. PubMed ID: 2119842
[TBL] [Abstract][Full Text] [Related]
7. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
8. Studies on the ocular pharmacology of prostaglandin D2.
Woodward DF; Hawley SB; Williams LS; Ralston TR; Protzman CE; Spada CS; Nieves AL
Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):138-46. PubMed ID: 2298534
[TBL] [Abstract][Full Text] [Related]
9. Interaction of BW A868C, a prostanoid DP-receptor antagonist, with two receptor subtypes in the rabbit isolated saphenous vein.
Lydford SJ; McKechnie KC; Leff P
Prostaglandins; 1996 Aug; 52(2):125-39. PubMed ID: 8880898
[TBL] [Abstract][Full Text] [Related]
10. Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells.
Chan CL; Jones RL; Lau HY
Br J Pharmacol; 2000 Feb; 129(3):589-97. PubMed ID: 10711359
[TBL] [Abstract][Full Text] [Related]
11. Biological activity of metabolites of PGD2 on canine proximal colon.
Rangachari PK; Betti PA
Am J Physiol; 1993 May; 264(5 Pt 1):G886-94. PubMed ID: 8498516
[TBL] [Abstract][Full Text] [Related]
12. Partial agonist effects of BW A868C, a selective DP receptor antagonist, on Cl- secretion in dog tracheal epithelium.
Liu YJ; Jackson DM; Blackham A; Leff P
Eur J Pharmacol; 1996 May; 304(1-3):117-22. PubMed ID: 8813592
[TBL] [Abstract][Full Text] [Related]
13. Intestinal effects of isoprostanes: evidence for the involvement of prostanoid EP and TP receptors.
Elmhurst JL; Betti PA; Rangachari PK
J Pharmacol Exp Ther; 1997 Sep; 282(3):1198-205. PubMed ID: 9316826
[TBL] [Abstract][Full Text] [Related]
14. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
[TBL] [Abstract][Full Text] [Related]
15. A functional study on prostanoid receptors involved in cultured human iridal melanocyte stimulation.
Hu DN; McCormick SA; Woodward DF
Exp Eye Res; 2001 Jul; 73(1):93-100. PubMed ID: 11428866
[TBL] [Abstract][Full Text] [Related]
16. Functional subtyping of histamine receptors on the canine proximal colonic mucosa.
Rangachari PK; Prior T
J Pharmacol Exp Ther; 1994 Nov; 271(2):1016-26. PubMed ID: 7965764
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C.
Hamid-Bloomfield S; Whittle BJ
Br J Pharmacol; 1989 Feb; 96(2):307-12. PubMed ID: 2647205
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin D2 regulates human colonic ion transport via the DP1 receptor.
Medani M; Collins D; Mohan HM; Walsh E; Winter DC; Baird AW
Life Sci; 2015 Feb; 122():87-91. PubMed ID: 25534438
[TBL] [Abstract][Full Text] [Related]
19. Identification of a single (FP) receptor associated with prostanoid-induced Ca2+ signals in Swiss 3T3 cells.
Woodward DF; Lawrence RA
Biochem Pharmacol; 1994 Apr; 47(9):1567-74. PubMed ID: 8185669
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of the prostanoid DP receptor in human myometrium.
Fernandes B; Crankshaw D
Eur J Pharmacol; 1995 Sep; 283(1-3):73-81. PubMed ID: 7498323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
